Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Benjamin Israelow
Affiliation
Yale University School of Medicine
ORCID
Career Start Year
2010
Papers
33
H Index
22
Expertise
CM4AI Collaborator
Wade Schulz (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37585505
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination.
Sci Transl Med
2023
34718647
Longitudinal Immune Profiling of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection in a Solid Organ Transplant Recipient.
J Infect Dis
2022
35350207
Inhalable polymer nanoparticles for versatile mRNA delivery and mucosal vaccination.
bioRxiv
2022
35768006
Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.
Cell
2022
35483404
Inflammasome activation in infected macrophages drives COVID-19 pathology.
Nature
2022
36302057
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses.
Science
2022
34921308
A humanized mouse model of chronic COVID-19.
Nat Biotechnol
2022
34914544
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells.
Sci Immunol
2022
35228707
Multiscale PHATE identifies multimodal signatures of COVID-19.
Nat Biotechnol
2022
34611663
Inflammasome activation in infected macrophages drives COVID-19 pathology.
bioRxiv
2022
34757384
A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice.
J Exp Med
2022
33433624
Neuroinvasion of SARS-CoV-2 in human and mouse brain.
J Exp Med
2021
33758831
A humanized mouse model of chronic COVID-19 to evaluate disease mechanisms and treatment options.
Res Sq
2021
34623900
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2.
Sci Immunol
2021
34159330
A stem-loop RNA RIG-I agonist confers prophylactic and therapeutic protection against acute and chronic SARS-CoV-2 infection in mice.
bioRxiv
2021
34145437
Author Correction: Delayed production of neutralizing antibodies correlates with fatal COVID-19.
Nat Med
2021
34031656
Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2.
bioRxiv
2021
34230210
Kynurenic acid may underlie sex-specific immune responses to COVID-19.
Sci Signal
2021
34166473
Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2.
PLoS Pathog
2021
32750141
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.
J Exp Med
2020
33398304
Kinetics of antibody responses dictate COVID-19 outcome.
medRxiv
2020
32577695
Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes.
medRxiv
2020
32577647
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.
bioRxiv
2020
32935108
Neuroinvasion of SARS-CoV-2 in human and mouse brain.
bioRxiv
2020
32846427
Sex differences in immune responses that underlie COVID-19 disease outcomes.
Nature
2020
28442604
Hepatitis C Virus Indirectly Disrupts DNA Damage-Induced p53 Responses by Activating Protein Kinase R.
mBio
2017
27303683
Viral Determinants of miR-122-Independent Hepatitis C Virus Replication.
mSphere
2015
24833036
HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
Hepatology
2014
25403145
Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors.
Nat Commun
2014
23555257
Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.
PLoS Pathog
2013
22751203
High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries.
Nat Methods
2012
21917968
HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle.
J Virol
2011
20844048
Species-specific regions of occludin required by hepatitis C virus for cell entry.
J Virol
2010
1 - 33 of 33
Column Actions
Search
Recommended Authors
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
2017
Number of shared co-authors
0
Kathleen M Voss
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
2016
Number of shared co-authors
0
Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Career Start Year
2015
Number of shared co-authors
0
Camille R Simoneau
Gladstone Institute of Virology
Career Start Year
2015
Number of shared co-authors
0
Sarah R Leist
University of North Carolina at Chapel Hill
Career Start Year
2014
Number of shared co-authors
1
Erik Van Dis
University of California berkeley
Career Start Year
2014
Number of shared co-authors
1
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year
2013
Number of shared co-authors
0
R??my Robinot
Institut Pasteur, Universite Paris Cite, CNRS UMR 9
Career Start Year
2012
Number of shared co-authors
0
Siyuan Ding
Washington University School of Medicine
Career Start Year
2009
Number of shared co-authors
2
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year
2008
Number of shared co-authors
2
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Career Start Year
2008
Number of shared co-authors
0
Vineet D Menachery
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
0
Mohsan Saeed
Boston University Chobanian and Avedisian School of Medicine
Career Start Year
2007
Number of shared co-authors
1
Stephanie A Montgomery
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year
2006
Number of shared co-authors
1
Richard Green
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
2005
Number of shared co-authors
0
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year
2003
Number of shared co-authors
1
Lisa E Gralinski
University of North Carolina at Chapel Hill
Career Start Year
2002
Number of shared co-authors
0
Benjamin R tenOever
NYU Grossman School of Medicine
Career Start Year
2001
Number of shared co-authors
0
Renee C Ireton
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
1997
Number of shared co-authors
0
Larissa B Thackray
Washington University School of Medicine
Career Start Year
1996
Number of shared co-authors
0
Shelly J Robertson
National Institute of Allergy and Infectious Diseases
Career Start Year
1995
Number of shared co-authors
0
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
0
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
1993
Number of shared co-authors
0
Lucy Thorne
University College London
Career Start Year
1992
Number of shared co-authors
0
Chien-Te K Tseng
The University of Texas Medical Branch
Career Start Year
1991
Number of shared co-authors
0
Mark T Heise
University of North Carolina at Chapel Hill.
Career Start Year
1990
Number of shared co-authors
0
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year
1988
Number of shared co-authors
1
Bart L Haagmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
0
Michael S Diamond
Washington University School of Medicine
Career Start Year
1982
Number of shared co-authors
2
Ralph S Baric
University of North Carolina
Career Start Year
1981
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Akiko Iwasaki
Yale University
Co-authored papers
24
Tianyang Mao
Yale University School of Medicine
Co-authored papers
18
Craig B Wilen
Yale School of Medicine
Co-authored papers
11
Eric Song
Yale University
Co-authored papers
10
Peiwen Lu
Yale University School of Medicine
Co-authored papers
10
Shelli F Farhadian
Yale School of Medicine
Co-authored papers
9
Aaron M Ring
Yale University School of Medicine
Co-authored papers
9
Carolina Lucas
Yale School of Medicine
Co-authored papers
9
Albert I Ko
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers
8
Nathan D Grubaugh
Yale School of Public Health
Co-authored papers
7
Patrick Wong
Yale School of Medicine
Co-authored papers
7
Arnau Casanovas-Massana
School of Public Health, Yale University
Co-authored papers
7
Chantal B F Vogels
Yale School of Public Health
Co-authored papers
7
Charles S Dela Cruz
Department of Microbial Pathogenesis Yale University New Haven
Co-authored papers
7
Saad B Omer
Yale School of Public Health
Co-authored papers
6
Ji Eun Oh
College of Science & Industry Convergence, Ewha Womans University
Co-authored papers
6
Adam J Moore
Yale School of Public Health
Co-authored papers
5
Anne L Wyllie
Yale School of Public Health
Co-authored papers
5
Yuval Kluger
Yale University School of Medicine
Co-authored papers
4
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Co-authored papers
4
M Catherine Muenker
Yale School of Public Health
Co-authored papers
4
Maria Tokuyama
Yale University School of Medicine
Co-authored papers
4
Arvind Venkataraman
Christian Medical College
Co-authored papers
4
Wade Schulz (CM4AI)
Yale University
Co-authored papers
3
John B Fournier
Yale University School of Medicine
Co-authored papers
3
Maria E Sundaram
Dalla Lana School of Public Health, University of Toronto
Co-authored papers
2
Mallory K Ellingson
Yale University School of Public Health, 60 College St
Co-authored papers
2
Anna Marie Pyle
Yale University, USA Howard Hughes Medical Institute
Co-authored papers
2
Amit Meir
Boyer Center for Molecular Medicine, Yale University
Co-authored papers
2
Isabel M Ott
Yale School of Public Health
Co-authored papers
2
1 - 30